Introducing

ReDS™

ReDS™ is an easy-to-use, noninvasive system for the monitoring and management of lung fluid in patients with Heart Failure and other fluid management problems.




    Introducing

    ReDS™

    ReDS™ is an easy-to-use, noninvasive system for the monitoring and management of lung fluid in patients with Heart Failure and other fluid management problems.




      ACCURATE.1
      ABSOLUTE.
      ACTIONABLE.

      LUNG FLUID MEASUREMENT FOR HEART FAILURE PATIENTS

      Request more info

      Striving to lead a new standard of care in heart failure

      Absolute
      Noninvasive readings provide an absolute number for fluid content.
      Accurate
      Correlated to CT, the most accurate extant method for measuring fluid.
      Actionable
      Reducing readmissions with actionable data to guide treatment.

      Heart Failure:

      A Vicious Cycle of Hospital Readmissions
      • Heart Failure is the #1 reason for hospital admissions in patients over 65
      • Over 1 million Heart Failure hospitalizations occur each year
      • As many as 25% of patients are readmitted within 30 days
      • Patient condition deteriorates with each hospital readmission
      • 24% of patients die within 1 year of their heart failure diagnosis

      The Need

      Did you know that some $21 billion is spent every year on the constant discharges and readmissions of Heart Failure patients? Heart Failure can be a vicious cycle of stress, admissions, and discharges.

      Our Solution

      The ReDS lung fluid monitoring system is a decision support tool that assists practitioners in better monitoring Heart Failure patients and suggesting treatment programs that are right for them, such as dietary and medication recommendations. ReDS is the fifth vital sign for heart failure patients. ReDS provides accurate, absolute, and actionable readings that allow the monitoring and treatment of patients, keeping them out of the hospital.
      In the emergency department (ED), every second counts. ED providers must provide accurate, actionable assessments quickly and confidently, to keep patients safe and to improve the speed and efficiency of patient flow. By providing an accurate, fast and absolute measurement, ReDS helps improve triage and decision support in the ED, and can help avoid unnecessary hospitalizations. Download brochure
      In the emergency department (ED), every second counts. ED providers must provide accurate, actionable assessments quickly and confidently, to keep patients safe and to improve the speed and efficiency of patient flow. By providing an accurate, fast and absolute measurement, ReDS helps improve triage and decision support in the ED, and can help avoid unnecessary hospitalizations. Download brochure
      The ReDS system allows providers, e.g., cardiologists, hospitalists and mid-levels, to quickly and accurately measure the degree of a patient’s congestion in just 90 seconds, optimizing care while keeping patient hospital stays as short as possible. “It can create a win-win for the patient and the hospital,” says William T. Abraham, MD, FACP, FACC, Director of the Division of Cardiovascular Medicine at Ohio State University. “Patients get targeted care and providers have an objective measure of when lung congestion has been removed.” Download brochure
      With the ReDS lung fluid measurement system, SNF staff can directly measure lung fluid in patients with chronic Heart Failure in just 90 seconds as part of their routine vitals assessment and make sure that patients are staying dry and avoiding recurrent volume overload. The ReDS system can also be used on residents complaining of shortness of breath to help assess what role Heart Failure may be playing in their symptoms, and help refine diagnosis and treatment without a visit to the ER. Download brochure

      What does ReDS™ measure?

      What is Normal Lung Fluid Content?

      Normal lung fluid content is around 20-30%. ReDS can help determine a patient’s fluid status and if they are in an elevated state. This can be valuable data on the heart failure floor, in the emergency department, discharge, or anywhere that treatment decisions are made for patients with fluid management conditions.

      ReDS Target Volume

      Graphic_ReDS_TargetVolume_svg Over 50% Over 41% 36-41% 21-35% Below 21% Extreme OverloadHypervolemic StatusPossible Hypervolemic StatusOptimal Volume StatusBelow Normal

      Benefits of ReDS™ Technology

      Versatility Across the Continuum of Care Lung fluid monitored at the hospital, clinic, CHF ward, and the ED Regular remote monitoring of lung fluid at home

      Noninvasive system Worn over patient’s clothes

      Fast Measurement takes only 90 seconds

      Absolute measurement Requires no benchmark or historical data to evaluate

      Clinical study-proven economic benefits Reduces hospital readmissions by 87%* Demonstrates high patient compliance

      Comprehensive solution Offers call center support and a physician portal

      Physiologic Markers of
      Acute Decomposition

      Early fluid detection -30 -20 -10 0 HEMODYNAMICALLY STABLE VOLUME & PRESSURE CHANGE AUTONOMIC ADAPTION INTRATHORACIC IMPEDANCE WEIGHT CHANGE HOSPITALIZATION PRESYMPTOMATIC CONGESTION DECOMPENSATION TIME PRECEDING HOSPITALIZATION (DAYS)
      ReDS Provides Early Fluid Detection

      Indications for Use

      ReDS™ is intended for use by qualified health care practitioners and by patients, under the direction of a physician, in hospitals, hospital-type facilities and home environments, for the noninvasive monitoring and management of patients with fluid management problems in a variety of medically accepted clinical applications.

      Fluid management problems

      Taking diuretic medication

      Living with heart failure

      Recovering from Coronary Artery Disease or a related event

      Break the cycle of readmission with ReDS™

      Accurate Lung Fluid Measurement with ReDS™: The missing link in guiding treatment, improving quality of life, and reducing readmissions for Heart Failure patients.

      Request more info
      Ref 1: Amir, Off er et al. “Validation of Remote Dielectric Sensing (ReDS™) Technology for Quantification of Lung Fluid Status: Comparison to High Resolution Chest Computed Tomography in Patients With and Without Acute Heart Failure.” International Journal of Cardiology 221. (2016) 841-846.